Ella Evron

Johns Hopkins University — United States

Biochemistry, Genetics and Molecular Biology · Life Sciences

28h-index4.5kcitations87works0.32yr avg
OpenAlex↗ORCID↗Google Scholar↗Lab page↗

Accepting Students?

No reports yet. Know if this professor is taking students?

Research Topics

Breast Cancer Treatment Studies(20), BRCA gene mutations in cancer(17), Epigenetics and DNA Methylation(13), Cancer Genomics and Diagnostics(12), Advanced Breast Cancer Therapies(11)

Publications85 total

Correction: Hypermethylation of 14-3-3 σ (stratifin) is an early event in breast cancer
Oncogene·2025Open Access
Abstract P5-07-30: Prophylactic irradiation to the contralateral breast for BRCA pathogenic-variant carriers with early-stage breast cancer: 10 years results
Clinical Cancer Research·2025
Abstract P1-09-26: Genomic analysis of circulating tumor DNA (ctDNA) from patients with triple-negative, HER2-mutant metastatic breast cancer treated with neratinib as monotherapy or in combination with trastuzumab in the SUMMIT trial
Clinical Cancer Research·2025
Prophylactic Irradiation of the Contralateral Breast for <i>BRCA</i> Carriers With Early Breast Cancer
JAMA Oncology·2025
ER + HER2- early-stage breast cancer: association of HER2 expression, tumor characteristics, and outcomes
Breast Cancer Research and Treatment·2024Open Access
Efficacy and genomic analysis of <i>HER2</i>-mutant, metastatic triple-negative breast cancer treated with neratinib alone or in combination with trastuzumab in the phase 2 SUMMIT basket trial.
Journal of Clinical Oncology·2024· 2 cited
Abstract PO5-01-08: The impact of Human Epidermal growth factor Receptor 2 (HER2) expression by RT-PCR on tumor characteristics and outcome in estrogen receptor (ER) positive, HER2 negative early-stage breast cancer
Cancer Research·2024
Second breast cancer: recurrence score results, clinicopathologic characteristics, adjuvant treatments, and outcomes—exploratory analysis of the Clalit registry
npj Breast Cancer·2023· 3 citedOpen Access
Clinical outcomes in estrogen receptor-positive early-stage breast cancer patients with Recurrence Score 26-30: observational real-world cohort study
npj Breast Cancer·2023· 4 citedOpen Access
Leveraging Comprehensive Health Records for Breast Cancer Risk Prediction: A Binational Assessment
Zenodo (CERN European Organization for Nuclear Research)·2023· 3 citedOpen Access
Leveraging Comprehensive Health Records for Breast Cancer Risk Prediction: A Binational Assessment
PubMed·2023· 2 citedOpen Access
Nonsurgical Options for Risk Reduction of Contralateral Breast Cancer in <i>BRCA</i> Mutation Carriers With Early-Stage Breast Cancer
Journal of Clinical Oncology·2022· 11 cited
Controversies and Open Questions in Management of Cancer-Free Carriers of Germline Pathogenic Variants in BRCA1/BRCA2
Cancers·2022· 7 citedOpen Access
149P Clinical outcomes in ER+ breast cancer patients with recurrence score 26-30-guided therapy: Real-world data
Annals of Oncology·2022· 2 cited
Recurrence Score (RS) results, clinicopathologic characteristics, treatments, and outcomes in primary versus subsequent breast cancer (BC): Exploratory analysis of the Clalit Health Services (CHS) registry.
Journal of Clinical Oncology·2022
Genetic testing in patients with triple-negative or hereditary breast cancer
Current Opinion in Oncology·2021· 4 cited
Risk-Reducing Mastectomy and Reconstruction Following Prophylactic Breast Irradiation: Hope Sustained
Cancers·2021· 2 citedOpen Access
Abstract PS14-07: Ribociclib + letrozole in patients with hormone receptor-positive (HR+), human epidermal growth factor receptor-2-negative (HER2−) advanced breast cancer (ABC) and central nervous system metastases: Subgroup analysis of the phase IIIb CompLEEment-1 trial
Cancer Research·2021
Abstract OT-29-01: Tenacity: A phase 2, multicenter, open-label, single-arm study of AL101 monotherapy in patients with notch-activated triple negative breast cancer
Cancer Research·2021· 2 cited
Breast-Specific Epigenetic Regulation of DeltaNp73 and Its Role in DNA-Damage-Response of BRCA1-Mutated Human Mammary Epithelial Cells
Cancers·2020· 3 citedOpen Access
page 1 of 5Next →

Frequent Co-authors

Saraswati Sukumar(11), Bella Kaufman(8), Zev Sthoeger(8), Ayelet Avraham(6), Bella Nisenbaum(5), Georgeta Fried(5), Jeffrey R. Marks(4), Christopher B. Umbricht(4), Naomi Halachmi(4), David Sidransky(4), Salomon M. Stemmer(4), Shulamith Rizel(4), Noa Ben-Baruch(4), Ora Rosengarten(4), Hadassah Goldberg(4), Sorel Goland(4), Venu Raman(3), Dorian Korz(3), Kenji Okami(3), Lior Soussan‐Gutman(3)